Krug S - Search Results

1

Quantitative and functional analysis of core-specific T-helper cell and CTL activities in acute and chronic hepatitis B.

Löhr HF, Krug S, Herr W, Weyer S, Schlaak J, Wölfel T, Gerken G, Meyer zum Büschenfelde KH. Löhr HF, et al. Among authors: krug s. Liver. 1998 Dec;18(6):405-13. doi: 10.1111/j.1600-0676.1998.tb00825.x. Liver. 1998. PMID: 9869395

2

Treatment of advanced gastroenteropancreatic neuroendocrine neoplasia, are we on the way to personalised medicine?

Rinke A, Auernhammer CJ, Bodei L, Kidd M, Krug S, Lawlor R, Marinoni I, Perren A, Scarpa A, Sorbye H, Pavel ME, Weber MM, Modlin I, Gress TM. Rinke A, et al. Among authors: krug s. Gut. 2021 Sep;70(9):1768-1781. doi: 10.1136/gutjnl-2020-321300. Epub 2021 Mar 10. Gut. 2021. PMID: 33692095 Review.

3

Brain metastases in patients with neuroendocrine neoplasms: risk factors and outcome.

Krug S, Teupe F, Michl P, Gress TM, Rinke A. Krug S, et al. BMC Cancer. 2019 Apr 16;19(1):362. doi: 10.1186/s12885-019-5559-7. BMC Cancer. 2019. PMID: 30991982 Free PMC article.

4

Relevance of dihydropyrimidine-dehydrogenase and thymidylate-synthase in patients with pancreatic neuroendocrine neoplasms treated with 5-FU-based chemotherapy.

Krug S, Boch M, Nimphius W, Gress TM, Michl P, Rinke A. Krug S, et al. Pancreatology. 2017 Jan-Feb;17(1):139-145. doi: 10.1016/j.pan.2016.12.006. Epub 2016 Dec 22. Pancreatology. 2017. PMID: 28027897

5

Paraneoplastic brainstem encephalitis in a patient with exceptionally long course of a metastasized neuroendocrine rectum neoplasm.

Boch M, Rinke A, Rexin P, Seipelt M, Brödje D, Schober M, Gress TM, Michl P, Krug S. Boch M, et al. Among authors: krug s. BMC Cancer. 2014 Sep 22;14:691. doi: 10.1186/1471-2407-14-691. BMC Cancer. 2014. PMID: 25244967 Free PMC article.

6

Streptozocin-Based Chemotherapy in Patients with Advanced Neuroendocrine Neoplasms--Predictive and Prognostic Markers for Treatment Stratification.

Krug S, Boch M, Daniel H, Nimphius W, Müller D, Michl P, Rinke A, Gress TM. Krug S, et al. PLoS One. 2015 Dec 2;10(12):e0143822. doi: 10.1371/journal.pone.0143822. eCollection 2015. PLoS One. 2015. PMID: 26630134 Free PMC article.

7

Neuroendocrine tumours - Medical therapy: Biological.

Rinke A, Krug S. Rinke A, et al. Among authors: krug s. Best Pract Res Clin Endocrinol Metab. 2016 Jan;30(1):79-91. doi: 10.1016/j.beem.2015.09.004. Epub 2015 Oct 9. Best Pract Res Clin Endocrinol Metab. 2016. PMID: 26971845 Review.

8

Low dose DTIC is effective and safe in pretreated patients with well differentiated neuroendocrine tumors.

Mueller D, Krug S, Majumder M, Rinke A, Gress TM. Mueller D, et al. Among authors: krug s. BMC Cancer. 2016 Aug 18;16:645. doi: 10.1186/s12885-016-2642-1. BMC Cancer. 2016. PMID: 27538897 Free PMC article.

9

Impact of Therapy Sequence with Alkylating Agents and MGMT Status in Patients with Advanced Neuroendocrine Tumors.

Krug S, Boch M, Rexin P, Gress TM, Michl P, Rinke A. Krug S, et al. Anticancer Res. 2017 May;37(5):2491-2500. doi: 10.21873/anticanres.11590. Anticancer Res. 2017. PMID: 28476818

10

Clinicopathological hallmarks and biomarkers of colorectal neuroendocrine neoplasms.

Koenig A, Krug S, Mueller D, Barth PJ, Koenig U, Scharf M, Ellenrieder V, Michl P, Moll R, Homayunfar K, Kann PH, Stroebel P, Gress TM, Rinke A. Koenig A, et al. Among authors: krug s. PLoS One. 2017 Dec 12;12(12):e0188876. doi: 10.1371/journal.pone.0188876. eCollection 2017. PLoS One. 2017. PMID: 29232390 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

414 results

Search Page

Filters